Safeguarding against substandard/counterfeit drugs: Mitigating a macroeconomic pandemic

Research in Social and Administrative Pharmacy

Volumn 5, Issue 1, 2009, Pages 4-16

  Wertheimer, Albert I ^a   Norris, Jeremiah ^b  

^a TEMPLE UNIVERSITY   (United States)

^b HUDSON INSTITUTE   (United States)

Author keywords

Counterfeit drugs; Economic consequences; Fake HIV AIDS drugs; Prevention; Substandard drugs; Vigilance

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG INDUSTRY; ECONOMICS; EPIDEMIC; FORGERY; HUMAN; PUBLIC HEALTH; REVIEW; STANDARD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DISEASE OUTBREAKS; DRUG INDUSTRY; FRAUD; HUMANS; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH;

EID: 61849136738     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.05.002     Document Type: Review

References (45)

1. Jeremiah Norris. Don't blame patents. The New York Sun. August 28, 2003.
2. Terrence Blaschke. Generic drugs for HIV/Aids is good news, but manufacturing standards must be monitored. Financial Times. October 6, 2003.
3. Gallo R.C., and Montagnier L. Prospects for the future. Science 298 (2002) 1730
4. Cohen J. Summary sheet: corruption in the pharmaceutical sector. Transparency International. Available at: http://www.globalaging.org/health/world/2006/world%20HE%20Feb1%20Pharma% 20corruption%20(phcorrupt).pdf. Accessed 14.04.06.
5. World Health Organization, Fact Sheet no.275, Substandard and Counterfeit Medicines. Available at: http://www.who.int/mediacentre/factsheets/2003/fs275/en/. Accessed 16.04.06.
6. U.S. Food and Drug Administration. Counterfeit drug task force interim report. Available at: (October 2003). http://www.fda.gov/oc/initiatives/counterfeit/report/interim_report Accessed 14.04.06
7. IMS Health. (Ip-health) now $602 billion in annual sales: IMS World Pharmaceutical Market Summary 3/2006. Available at: http://lists.essential.org/pipermail/ip-health/2006-April/009337.html. Accessed 03.05.06.
8. Meghna Mehta. B-191 World Pharmaceutical Market, BCC Research. Available at: http://www.bccresearch.com/biotech/B191.html. Accessed 02.05.06.
9. Scott Gottlieb. Speech before Parental Drug Association Conference, March 3, 2006. Available at: http://www.fda.gov/oc/speeches/2006/pda0303html. Accessed 13.04.06.
10. IFPMA, quality and counterfeiting. Available at: http://www.ifpma/org/issues/issues_quality.aspx. Accessed 13.04.06.
11. Debrework Zewdie. AIDS Resist Adher 18 suppl 3 (June 2004) 10-11
12. Robert Redfield. Presentation to the Children's AIDS Fund. Washington, DC; May 10, 2004.
13. International Treatment Preparedness Coalition. Missing the target: off target for 2010: how to avoid breaking the promise of Universal Access. Available at: (May 24, 2006). http://www.aidstreatmentaccess.org/itpcupdatefinal.pdf Accessed 30.05.06
14. Michele Forzley. Combating counterfeit drugs, World Health Organization, Geneva, Sept 2005 p. 7.
15. World Health Organization. Price, Availability, and Affordability: An International Comparison of Chronic Disease Medicines (May 2006), World Health Organization, Geneva
16. Wyatt Yankus. Counterfeit Drugs: Coming to a Pharmacy Near You (July 2006), American Council on Science and Health
17. Michele Forzley. Combating counterfeit. p. 8.
18. Berndt E.R., and Finkelstein S. Loss of work productivity due to illness and medical treatment. J. Occup and Environ Med 41 (1999) 949
19. Statement of Jason P. Ahern. U.S. House of Representatives, Committee on Energy and Commerce. The Safety of Imported Drugs. December 13, 2005.
20. WHO. World Health Organization Counterfeit Drugs: Report of the International Workshop on Counterfeit Drugs. HO/DRS/CFD98.1 (November 26-28, 1997), WHO, Geneva, Switzerland
21. USFDA. Counterfeit drug task force interim report. Available at: http://www.fda.gov/oc/initiatives/counterfeit/report/interim_report. Accessed 14.04.06.
22. Francis PA. National Programme to Counter Fake Drugs. Editorial, Pharmabiz.com. Available at: http://www.Pharmabiz.com/article/detnews.asp?articleid=123288sectionid-4 7. Accessed 16.04.06.
23. Rudolf PM and Bernstein IB in Medical Biology: On Counterfeit Drugs. Science Week. Available at: http://www.scienceweek.com/2004/sc040910-4.htm. Accessed 13.04.06.
24. Transparency International. The Global Coalition Against Corruption. Global Corruption report 2006. Corruption in the Health Sector: Seeking the Cure. Feb 1, 2006. Transparency International USA and the Center for Global Development presented the launch of the "Transparency International Global corruption Report 2006." Available at: http://www.cgdev.org/doc/event%20docs/transcript_2.1.06.pdf. Accessed 16.04.06.
25. Nurses for patient safety: targeting counterfeit and substandard medicines. Available at: http://www.inc.ch/indkit2005.pdf. Accessed 12.04.06.
26. Latin America battles counterfeiting drugs threat. Daily International Pharmacy Alert: Washington Business. Information 2 292 (2006)
27. Cohen. Summary sheet: corruption in the pharmaceutical sector. Transparency International. Available at: http://www.globalaging.org/health/world/2006/world%20HE%20Feb1%20Pharma% 20corruption%20(phcorrupt).pdf. Accessed 14.04.06.
28. AllAfrica.com. Ghana: governments make us sick. Ghana Chronicle. Available at: http://www.allaafrica.com/stories/200604070596.html. Accessed 17.04.06.
29. WHO. Combating counterfeit drugs: building effective international collaboration. Declaration of Rome. February 18, 2006.
30. A health tomorrow? Health system facts & trends affecting business decision today. World Business Council for sustainable development. Available at: http://www.wbcd.ch/DocRoot/fcktkuiQcizhGxbL60v0/healthfacts_pdf. Accessed 16.04.06.
31. Abiodun Raufu. India agrees to help Nigeria tackle the import of fake drugs. Available at:. Br Med J (June 7, 2003). http://www.bmj.bmjjournals.com/cgi/content/full/326/7401/7234-d Accessed 16.04.06
32. Kristin Paterson, and Olatubosum Obileye. Access to Drugs for HIV/AIDS and Related Opportunistic Infections in Nigeria (September 2002), USAID, Washington, DC. http://www.policyproject.com/pub/countryreports/NIG_ADI.pdf Accessed 17.04.06
33. Howard Zucker M.D. Combating Counterfeit Drug: Building Effective International Collaboration (February 16, 2006), World Health Organization, Rome, Italy. http://www.who.int/medicines_technologies/media/Combating-Counterfeit-Dr ugs2006_Speech-by-Dr-Howard-Zucker.pdf Accessed 30.06.06
34. TopeAkinwande. Lethal 'Cures' Plague Africa. Available at:. World Press Rev (February 2004). http://www.worldpress.org/Africa/1749.cfm Accessed 13.04.06
35. Hank McKinell. Address the United Nations Global Compact Leaders Summit on countering corruption. Available at: (June 24, 2004). http://www.pfizer.com/pfizer/are/news_releases/2004pr/mn_2004_0624.jsp Accessed 19.04.06
36. Cohen J., Montoya J.C., et al. Corruption and Pharmaceuticals: Strengthening Good Governance. Brown Bag Lunch Seminar (April 4. 2006), World Bank, Washington, DC
37. Public Law 100-293. Prescription Drug manufacturing Act. April 22, 1988.
38. FDA. Combating counterfeit drugs: a report of the Food and Drug Administration. Available at: http://www.fda.gov/oc/initiatives/counterfeit/report02_04.html. Accessed 11.04.06.
39. WHO Regional Office for the Western Pacific, Essential Drug Medicines Policy. Available at: http://www.wpro.who.int/NR/rdonlyres/C7BFA66C-64CF-4109-9254-484FE520D94 4/0/EDMP_June05.pdf. Accessed 12.04.06.
40. Bale HE, Jr. Counterfeit medicines: the role of industry and pharmacists. IFPMA News. Available at:http://www.ifpma.org/News/EspeechDetail.aspx?nID=25. Accessed 12.04.06.
41. The GPHF-Minilab. Protection against counterfeit and substandard pharmaceuticals. German Pharma Health Fund. Available at: http://www.gphf.org/web_en/projekte/minilab/index.htm. Accessed 13.04.06.
42. Council of Europe. Specific projects: counterfeit medicines. Available at: http://www.coe.int/T/E?Social_Cohesion/soc-sp/Public_Health/Pharma_and_M edicine/Spec. Accessed 03.05.06.
43. SafeMedicines.org. Available at: http://www.safemedicines.org/resources/001883.html. Accessed 24.04.06.
44. Pfizer using RFID to Fight Fake Viagra. RFID J. Available at: http://www.rfidjournal.com/article/articleview/2075/1/1. Accessed 12.04.06.
45. GSK to tag antiretroviral drug Trizivir bottles shipped to US with tracking device in pilot project to prevent counterfeiting. Available at: (March 24, 2006). http://www/kaisernetwork.org/Daily_reports/rephiv-recent.cfm?dr_cat=1 &show=yes Accessed 16.04.06